Literature DB >> 28219713

Effect of doxorubicin-induced ovarian toxicity on mouse ovarian granulosa cells.

Ting Zhang1, Wan Hong He2, Ling Lin Feng2, Hao Guang Huang3.   

Abstract

The objective of this study was to identify the effect of doxorubicin-induced ovarian toxicity on mouse ovarian granulosa cells. After granulosa cells were treated with doxorubicin at the final concentrations of 0, 0.4, 0.8, and 1.6 μg/ml for 24 h, cell apoptosis was detected by DAPI staining or caspase-3/7 fluorescence probe; ROS was determined by 2', 7'-dichlorodihydrofluorescin diacetate fluorescence probe; mitochondrial membrane potential was detected by rhodamine-123 fluorescence probe; and mRNA expression levels of Bax, Bcl-2, p53, FSHR, StAR, P450scc and P450arom were analyzed by RT-PCR. Results indicated that doxorubicin could induce apoptosis of granulosa cells (p < 0.01); increase ROS generation (p < 0.05 or p < 0.01); decrease mitochondrial membrane potential (p < 0.05); increase mRNA expression levels of Bax, Bcl-2, and p53 (p < 0.001); enhance mRNA expression level of StAR (p < 0.01 or p < 0.001); and inhibit mRNA expression level of P450scc in granulosa cells (p < 0.05 or p < 0.001). The mRNA expression levels of FSHR and P450arom were not influenced by doxorubicin. We suggest that the ovarian toxicity of doxorubicin was associated with apoptosis of granulosa cells, ROS accumulation, and decline of mitochondrial membrane potential in granulosa cells. In addition, cell apoptosis was regulated by Bax, Bcl-2, and p53, and hormone generation could be influenced by StAR and P450scc.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bax, Bcl-2; Chemotherapy; Doxorubicin; Granulosa cells; Oocyte; Premature ovarian failure (POF); Reactive oxygen species; p53

Mesh:

Substances:

Year:  2017        PMID: 28219713     DOI: 10.1016/j.yrtph.2017.02.012

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN: 0273-2300            Impact factor:   3.271


  7 in total

1.  Epigallocatechin-3-gallate inhibits doxorubicin-induced inflammation on human ovarian tissue.

Authors:  R Fabbri; M Macciocca; R Vicenti; G Caprara; M P Piccinni; R Paradisi; P Terzano; A Papi; R Seracchioli
Journal:  Biosci Rep       Date:  2019-05-14       Impact factor: 3.840

Review 2.  Ovarian damage from chemotherapy and current approaches to its protection.

Authors:  N Spears; F Lopes; A Stefansdottir; V Rossi; M De Felici; R A Anderson; F G Klinger
Journal:  Hum Reprod Update       Date:  2019-11-05       Impact factor: 15.610

3.  Resveratrol attenuates doxorubicin-induced meiotic failure through inhibiting oxidative stress and apoptosis in mouse oocytes.

Authors:  Jun Han; Huarong Wang; Tuo Zhang; Ziqi Chen; Ting Zhao; Lin Lin; Guoliang Xia; Chao Wang
Journal:  Aging (Albany NY)       Date:  2020-04-30       Impact factor: 5.682

4.  Ameliorative effect of recombinant human lactoferrin on the premature ovarian failure in rats after cyclophosphamide treatments.

Authors:  Shubin Li; Mengnan Liu; Hongmeng Ma; Qin Jin; Yuzhen Ma; Chunyu Wang; Jingyu Ren; Gang Liu; Yanfeng Dai
Journal:  J Ovarian Res       Date:  2021-01-21       Impact factor: 4.234

5.  Licochalcone B Ameliorates Liver Cancer via Targeting of Apoptotic Genes, DNA Repair Systems, and Cell Cycle Control.

Authors:  Kadry Sadek; Tarek Abouzed; Sherif Nasr; Moustafa Shoukry
Journal:  Iran J Pharm Res       Date:  2020       Impact factor: 1.696

6.  miR-644-5p carried by bone mesenchymal stem cell-derived exosomes targets regulation of p53 to inhibit ovarian granulosa cell apoptosis.

Authors:  Bo Sun; Yujia Ma; Fang Wang; Linli Hu; Yingpu Sun
Journal:  Stem Cell Res Ther       Date:  2019-11-29       Impact factor: 6.832

Review 7.  Role of reactive oxygen species in tumors based on the 'seed and soil' theory: A complex interaction (Review).

Authors:  Wei Liang; Xinying He; Jianqiang Bi; Tingting Hu; Yunchuan Sun
Journal:  Oncol Rep       Date:  2021-07-30       Impact factor: 3.906

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.